Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with

Masaki Shiota1, Hiroto Izumi, Akihide Tanimoto

  • 1Department of Molecular Biology, School of Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Japan.

Cancer Research
|March 26, 2009
PubMed

Insights

Programmed cell death protein 4 (PDCD4) inhibits cancer cell growth by down-regulating Y-box binding protein-1 (YB-1) through interaction with the transcription factor Twist1. PDCD4 influences chemoresistance, impacting cancer treatment strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Programmed cell death protein 4 (PDCD4) is implicated in cell growth regulation, but its precise mechanisms remain unclear.
  • Understanding PDCD4's role in transcription and translation is crucial for cancer therapy development.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which PDCD4 regulates cell growth.
  • To investigate the interaction between PDCD4, Twist1, and its target gene YB-1.
  • To assess the impact of PDCD4 on cancer cell chemoresistance.

Main Methods:

  • Investigated the direct interaction between PDCD4 and the transcription factor Twist1.
  • Analyzed the effect of PDCD4 on Twist1 DNA binding and YB-1 expression.
  • Conducted immunohistochemical analysis on clinical prostate cancer specimens.
  • Evaluated the sensitivity of PDCD4-overexpressing cells to various chemotherapeutic agents.

Main Results:

  • PDCD4 directly binds to the DNA binding domain of Twist1, inhibiting its activity and down-regulating YB-1 expression.
  • An inverse correlation between nuclear PDCD4 and YB-1 levels was observed in prostate cancer tissues.
  • PDCD4-mediated growth suppression was reversed by increased Twist1 or YB-1 expression.
  • PDCD4 overexpression enhanced sensitivity to cisplatin and paclitaxel, but not etoposide or 5-fluorouracil.

Conclusions:

  • PDCD4 negatively regulates YB-1 expression through interaction with Twist1, impacting cancer cell proliferation.
  • PDCD4 plays a significant role in modulating cancer cell chemoresistance.
  • These findings offer potential therapeutic targets for cancer treatment by modulating PDCD4-Twist1-YB-1 signaling.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...